What did Fagron pay for University Compounding Pharmacy?

Fagron acquired University Compounding Pharmacy for $41.5M in 2026, equivalent to 1.70x revenue. Target revenue was approximately $25.0M.

What does University Compounding Pharmacy do?

University Compounding Pharmacy is a pharmacy business.

What multiple did Fagron pay for University Compounding Pharmacy?

1.70x revenue, based on disclosed deal value of $41.5M and disclosed financials.

M&A TRANSACTION · 2026

University Compounding Pharmacy acquired by Fagron

$41.5M· 1.70x revenue

Target

University Compounding Pharmacy

Acquirer

Fagron

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$25.0M

EBITDA

—

Deal Value

$41.5M

EV/EBITDA

—

Context

This $41.5M acquisition of University Compounding Pharmacy by Fagron sits in the pharmacy sub-vertical. Fagron is acquiring as a strategic buyer; see how strategic acquirers typically price pharmacy businesses on our Pharmacy strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own pharmacy

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the University Compounding Pharmacy acquisition.

Citation: ExitValue.ai. (2026). University Compounding Pharmacy acquired by Fagron. https://exitvalue.ai/deals/university-compounding-pharmacy-acquired-by-fagron-hc-2026-0002